Scancell Share Discussion Threads

[inanaco] 05/6/2024 09:58

4/06/2024

England V Scotland Rain stop play cricket

Isle of Man damp patch's stop play ... with average speeds up to 135 mph no tyre can cope with the switch

Starmer Got Hammered, round 1 points decision 51/49

ADFVN carpentry class

Temp closure due to SC102 making a case (his own coffin)

[sci102] 05/6/2024 09:28

You see Bermuda only corrects obvious nonsense from inanaco et al to give the impression that they are impartial when in fact they are not. That's the truth

[sci102] 05/6/2024 09:00

BTW, are you associated with any funds that are scancell holders?

[dominiccummings] 05/6/2024 08:39

Sci102
Member since: 01 Dec 2023

Has only posted on Scancell.

[dominiccummings] 05/6/2024 08:38

FFS shut up. You are not going to get anyone to join your pathetic attempts to ramp the share price.

[sci102] 05/6/2024 08:23

BTW Bermuda is a dishonest a-hole and it will cost you your capital if you keep listening to them. How come this "expert" never answers to the point and only writes generic highschool-level essays? Inanaco's behaviour is actually more professional than Bermuda's, he at least tries to answer to the point, he may be clueless but at least he has some integrity. Think about it.

[sci102] 05/6/2024 06:07

So the company lied about passing to the second stage in Sept 2023? Because that is exactly what they said😅㈳7;😅😅

What is the drivel MT? Or is that the only word you know?

Let's not forget

Unless we coordinate to demand that the company explains

1. Why they gave an impossible guidance back in 2023 that scib 1 would be fully recruited (43 patients) by end of 2023, when in fact it took them from 2019 to September 2023 to recruit 16 patients and another 8 months to recruite another 11 (27 recruited in May 2024. Under what circumstances did they expect to recruit 43 patients till end of 2023 given the recruitment track record prior to the guidance?

2.Why do they refuse to update on SCIB1 current data when with only 2 additional patients and while SCOPE study with SCIB1 had already passed to Simon stage 2, they gave an update in November 2023 just before the cash raise and then never updated us formally again.

3. Why do they not upload the presentations/posters from the last 8 months on their website, while they used to do it before? Last data available to download are from November 2023, while there is plenty before that.

What will happen next is the share price is going to drip down steadily and then RM/Vulpes/other are going to take the company private for peanuts and we'll get shafted.


PS Do not listen to Bermuda, he is most likely associated to one of the funds. Especially if he says look at Redx. Redx kept investors updated regularly and had genuine reasons vs the share price dropping slowly because the company has released nothing substantial of all the work they have done since November 2023.

[dominiccummings] 04/6/2024 22:00

inanaco. Just for accuracy. THIS IS MY THREAD. I created it (albeit with an old avatar).

[inanaco] 04/6/2024 20:14

First RNS

Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announces positive data from the first stage in its Phase 2 SCOPE trial, investigating SCIB1 in combination with checkpoint inhibitors (CPIs) in advanced melanoma. Initial data from 11 patients showed an 82% objective response rate (ORR) to treatment, which is better than 70% ORR that the trial was configured to show.

Second RNS includes 2nd scan confirmation !!!


Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announces today it has two further responders on the SCOPE study, bringing the number of responders to 11 out of 13 patients. This is an objective response rate (ORR) of 85%. These responses have been verified in nine patients with a second scan at 19 weeks. Significantly, one of the patients has achieved a complete response following treatment. The two recent responders are scheduled to have their response confirmed in a subsequent scan.

[sci102] 04/6/2024 19:46

You went so far back in my comment history and that's all you learned?
😅😅😅😅


The stock market is about a lot of things, a major one is evaluating management. And yes, moaning for no reason is one to avoid, but I have several justified grievances.

[countbruga] 04/6/2024 19:33

Hey Sci102,
On 18/11/23, you posted -"Big mama says the stock market is for big girls and boys only. Whiners and moaners should stick to bonds, if that".
Take your own advice.

[sci102] 04/6/2024 19:12

"The SCOPE trial has now successfully transitioned into the second stage, which will recruit a further 27 patients (for a total of 43). The aim is to achieve at least 18 further responses (i.e., 27 responses in total) which would statistically demonstrate that SCIB1, in combination with doublet therapy, exceeds currently achievable ORRs. Recruitment is expected to be complete by the end of 2023 with data available in H1 2024."



How about correcting that nonsense bermuda. You only seem to contradict negative posts when I"m around. Also, would you be so kind as to answer my previous questions?
Ta

[sci102] 04/6/2024 18:54

BTW, you said before that Lindy had a lot of emails to catch up to because she was on vacation and while you did have a discussion/email exchange with her, you did not talk about scope. Was it the weather?

Since you do seem to have a decent relationship with the CEO, don't you think my questions are reasonable and justified? Why don't you ask her instead of talking about the weather then? 🙄

[sci102] 04/6/2024 18:50

OK Bermuda. Fair enough.

Do you agree that guidance is a major part of running a public company? And do you think that the guidance given in Sept 2023 was reasonable given the recruitment track record until then (and afterwards)?

[bermudashorts] 04/6/2024 18:47

Bermuda from Redmile here:) What on earth has Redx got to do with all of this?

[inanaco] 04/6/2024 18:40

Marcus agree ,.... but Dom had the same issues and now is back here ! after attempting to push me off here ! The BB's do contain Bullies ..

but i just dismiss them because they cannot debate

sc102
"""BTW, you still haven't found 1 (ONE) accelerated approval that is not second line+ and with other viable options. Doesn't that tell you something since you don't want to believe me?"""

we don't need to ... its you making the claim !! after Lindy has already said its possible

[sci102] 04/6/2024 18:15

I am not the one posting misleading info, because I am not the fool who thinks if I pump this day and night the share price will go up. It will once the CEO does her job as CEO.

Did scope pass stage 1 in Sept 2023 or Nov 2023, let's see how honest you are..

BTW, you still haven't found 1 (ONE) accelerated approval that is not second line+ and with other viable options. Doesn't that tell you something since you don't want to believe me?

Let's not forget

Unless we coordinate to demand that the company explains

1. Why they gave an impossible guidance back in 2023 that scib 1 would be fully recruited (43 patients) by end of 2023, when in fact it took them from 2019 to September 2023 to recruit 16 patients and another 8 months to recruite another 11 (27 recruited in May 2024. Under what circumstances did they expect to recruit 43 patients till end of 2023 given the recruitment track record prior to the guidance?

2.Why do they refuse to update on SCIB1 current data when with only 2 additional patients and while SCOPE study with SCIB1 had already passed to Simon stage 2, they gave an update in November 2023 just before the cash raise and then never updated us formally again.

3. Why do they not upload the presentations/posters from the last 8 months on their website, while they used to do it before? Last data available to download are from November 2023, while there is plenty before that.

What will happen next is the share price is going to drip down steadily and then RM/Vulpes/other are going to take the company private for peanuts and we'll get shafted.

PS Do not listen to Bermuda, he is most likely associated to one of the funds. Especially if he says look at Redx. Redx kept investors updated regularly and had genuine reasons vs the share price dropping slowly because the company has released nothing substantial of all the work they have done since November 2023.